CorMedix (CRMD) Non Operating Income (2018 - 2025)
CorMedix (CRMD) reported Non Operating Income of -$2.7 million for Q4 2025, down 607.74% on a YoY basis from $527797.0 in Q4 2024, and down 317.83% sequentially from $1.2 million in Q3 2025.
CorMedix (CRMD) Non Operating Income (2018 - 2025) Analysis & Trends
CorMedix (CRMD) has 5 years of Non Operating Income data on file, last reported at -$2.7 million in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income fell 607.74% year-over-year to -$2.7 million; the trailing twelve-month figure through Dec 2025 stood at -$124999.0 (down 104.12% YoY), and the FY2025 full-year result was -$125000.0, down 104.12% from the prior year.
- Non Operating Income retreated to -$2.7 million in Q4 2025, from $1.2 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.2 million in Q3 2025 to a low of -$2.7 million in Q4 2025.
- A 3-year average of $454364.6 and a median of $764456.0 in 2023 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 140.97% in 2025, while the deepest fall reached 607.74% in 2025.
- Tracing CRMD's Non Operating Income over 3 years: stood at $914715.0 in 2023, then slumped by 42.3% to $527797.0 in 2024, then tumbled by 607.74% to -$2.7 million in 2025.
- Business Quant data shows CRMD's Non Operating Income at -$2.7 million in Q4 2025, $1.2 million in Q3 2025, and $805983.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | -2.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.68 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 805,983.00 |
| Mar 31, 2025 | 518,618.00 |
| Dec 31, 2024 | 527,797.00 |
| Sep 30, 2024 | 510,524.00 |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 843,343.00 |
| Dec 31, 2023 | 914,715.00 |
| Sep 30, 2023 | 722,929.00 |
| Dec 31, 2019 | 71,639.00 |
| Sep 30, 2019 | -93,332.00 |
| Jun 30, 2019 | -219,580.00 |
| Mar 31, 2019 | -244,703.00 |
| Dec 31, 2018 | 10,286.00 |
| Sep 30, 2018 | 5,334.00 |
| Jun 30, 2018 | 15,239.00 |
| Mar 31, 2018 | 3,705.00 |